To decipher the molecular basis for the development of ovarian malignancy by looking for mtp53-binding proteins, we conducted co-IP with the anti-p53 antibody coupled with mass spectrometry (MS) analysis using a primary ovarian tumor sample with p53-S241F as detected by sequencing the TP53 gene exons. Here, TP53 is linked to ovarian neoplasm.